Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice

OBJECTIVE: To formulate a decision analysis model based on recently published data that addresses the dilemma, whether improvement in quality of life rationalises continued proton pump inhibitors (PPI) use despite the risk of gastric cancer (GC) in patients with functional dyspepsia (FD). DESIGN: A...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Open
Prif Awduron: Broide, Efrat, Eindor-Abarbanel, Adi, Shirin, Haim, Richter, Vered, Matalon, Shay, Leshno, Moshe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2020
Pynciau:
Gastroenterology and Hepatology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045183/
https://ncbi.nlm.nih.gov/pubmed/32051298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031091
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg